Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Meta May 20 layoff: As ‘doomsday’ nears, anxious employees stock up on free snacks, charges; apply preemptively
Employees have described the severance package as unexpectedly generous, calling it a “golden parachute” as the tech firm tries to soften the blow with 18 months of healthcare coverage.
Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focus - Upstox
Upcoming dividends, stock splits, buybacks this week: L&T, Havells India, ITC Hotels, Metropolis Healthcare, GM Breweries among others in focusUpstox
Athena opens northeast India’s largest integrated psychiatric hospital in Guwahati
Athena Behavioral Health opens Northeast India's largest private psychiatric hospital in Guwahati. This marks their fifth hospital nationwide. The facility offers integrated treatment for mental health and substance use disorders. It aims to address the region's growing needs and shortage of structured care. The launch signifies a crucial step in making quality mental healthcare accessible in underserved areas.
Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answer
The gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath bridges this gap by shifting the focus from simple automation to end-to-end orchestration
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).
Max Healthcare sets board meeting date to declare Q4 results 2026, final dividend for FY26
Max Healthcare Institute's Board of Directors will meet on May 21, 2026, to review financial results for the quarter and year ended March 31, 2026, and discuss a potential final dividend. The trading window for securities will remain closed until 48 hours after results are declared.
Five Stocks To Buy: NMDC, Tata Steel, Varun Beverages And More | May 15, 2026
Top picks include a consensus buy on NMDC, alongside Zydus Lifesciences, Varun Beverages (VBL), Max Healthcare, and Tata Steel.
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis Healthcare
Metropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic acquisitions will also play a key role. The company aims to expand services beyond pathology. This strategy will drive future growth and strengthen its market position.
Bajaj Group to enter healthcare biz with Rs 2k cr bet in Pune; expand to 7 cities in a decade
The Bajaj group is entering the healthcare sector. A significant investment of over Rs 2,000 crore is planned for Pune over the next three years. The group aims to establish a comprehensive healthcare model. This initiative will expand to multiple cities in the coming decade. The focus is on providing care from prevention to acute intervention.
Spire Healthcare shares surge 43% on Toscafund takeover proposal By Investing.com - Investing.com India
Spire Healthcare shares surge 43% on Toscafund takeover proposal By Investing.comInvesting.com India
Sakar Healthcare Q4 profit up 91% at Rs 11.02 crore
Sakar Healthcare announced strong financial results for the January-March quarter of 2025-26. Net profit surged by 91 percent to Rs 11.02 crore. Revenue from operations increased by 42 percent to Rs 71.09 crore. For the full fiscal year, net profit rose 74 percent to Rs 30.48 crore. Revenue jumped 42 percent to Rs 251.73 crore.
Metropolis Healthcare rallies after Q4 PAT climbs 75% YoY to Rs 51 cr
Metropolis Healthcare jumped 4.23% to Rs 571.30 after the company's consolidated net profit rose 74.67% to Rs 50.90 crore on 22.99% increase in revenue from operations to Rs 424.68 crore in Q4 FY26 over Q4 FY25.